Menu

Scientists Discover First Fluorescent Frog

The polka dot tree frog (Hypsiboas punctatus) glows under a blacklight, due to the presence of three fluorescent molecules in its lymph tissue and skin. 

Mar 14, 2017
Diana Kwon

JULIÁN FAIVOVICHA AND CARLOS TABOADA

When researchers placed a polka dot tree frog (Hypsiboas punctatus) under a black light, they made an unexpected discovery. The amphibian glowed with a bright, green-blue hue, the scientists reported Monday (March 13) in PNAS.

Fluorescence exists elsewhere in the animal kingdom, in some fish, sharks, and scorpions, for example. However, this is the first amphibian scientists have discovered with this trait. “We couldn’t believe it,” study co-author Julián Faivovich, a herpetologist at the University of Buenos Aires, told Nature.

Polka dog frogs contain biliverdin, a pigment found in some insects that gives them a dim red fluorescence, coauthor Carlos Taboada, a University of Buenos Aires herpetologist, told Nature. So the team expected the frogs to glow red under a UV flashlight, but instead, they emitted a brilliant, green-blue glow. The team also discovered that the fluorescence originated from three molecules, hyloin-L1, hyloin-L2 and hyloin-G1, in the frogs’ lymph tissue and skin.

“It would be interesting to investigate if [fluorescence] has a role in species recognition, or whether it facilitates the formation of couples,” Bibiana Rojas, an ecologist at the University of Jyväskylä, Finland, who was not involved in the work, told Chemistry World. “Fluorescence would be potentially very useful in a noisy environment and in a habitat with dense foliage, as it would make individuals brighter.”

It’s possible that other frog species are fluorescent, too. “Maybe we should be looking at every species we catch and trying to see if they fluoresce,” David Blackburn at the University of Florida who was not involved in the study, told New Scientist. “There’s very few frogs that have a feature that’s not found in any other frogs.” 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.